Haematology
Explore our latest news, features and educational resources in this specialist area.
SMC accepts treatment for paroxysmal nocturnal haemoglobinuria
Ravulizumab is accepted for restricted use.
SMC accepts fostamatinib for chronic immune thrombocytopenia
Treatment accepted for restricted use within NHS Scotland.
SMC accepts avatrombopag for severe thrombocytopenia
Avatrombopag is accepted for use within NHS Scotland for severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.
Ferric carboxymaltose (Ferinject▼): risk of symptomatic hypophosphataemia leading to osteomalacia and fractures
Monitor serum phosphate levels in patients treated with multiple high-dose administrations, or those on long-term treatment, and in those with pre-existing risk factors for hypophosphataemia.
